Mabion S.A. (FRA:272)
Germany flag Germany · Delayed Price · Currency is EUR
1.624
-0.030 (-1.81%)
Last updated: Dec 5, 2025, 8:18 AM CET

Mabion Company Description

Mabion S.A., a biopharmaceutical company, provides services as a contract development and manufacturing organization in the process development, analytics, and manufacturing of biologic medicines in Poland.

It offers drug substance manufacturing, fill and finish, gene to vial end-to-end development, process development, analytics, and banking services.

In addition, it offers cell line development, process development, production of a product for preclinical and clinical trials, development and validation of analytical methods, and preparation of the necessary documentation.

The company was founded in 2007 and is headquartered in Konstantynów Lódzki, Poland.

Mabion S.A.
Country Poland
Founded 2007
Industry Biological Products, Except Diagnostic Substances
Employees 213
CEO Krzysztof Kaczmarczyk

Contact Details

Address:
Medical Biotechnology Scientific and Industrial Complex
Konstantynów Lódzki, 95-050
Poland
Phone 48 42 207 7890
Website mabion.eu

Stock Details

Ticker Symbol 272
Exchange Frankfurt Stock Exchange
Fiscal Year January - December
Reporting Currency PLN
SIC Code 2836

Key Executives

Name Position
Krzysztof Kaczmarczyk Chief Executive Officer
Grzegorz Grabowicz Chief Financial Officer
Julita Balcerek Chief Operating Officer